Stockscreener 앱 받기
15.38
0.71%
-0.11
시간 외 거래:
15.74
0.36
+2.34%
전일 마감가:
$15.49
열려 있는:
$15.52
하루 거래량:
415.18K
Relative Volume:
1.83
시가총액:
$424.25M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-18.09
EPS:
-0.85
순현금흐름:
$-9.08M
1주 성능:
-2.07%
1개월 성능:
+24.33%
6개월 성능:
+185.34%
1년 성능:
+126.51%
1일 변동 폭
$15.24
$15.77
1주일 범위
$15.15
$16.59
52주 변동 폭
$5.105
$17.47
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
15.38 | 424.25M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
113.11 | 196.18B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
360.05 | 137.26B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.32 | 131.64B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
79.88 | 102.43B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.03 | 43.66B | 6.60B | 4.16B | 490.10M | 6.93 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Jane Street Group LLC Has $1.14 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Jane Street Group LLC - MarketBeat
Long Term Trading Analysis for (CLPT) - Stock Traders Daily
Conway Capital Management Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 26% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint: Fundamentals Continue To Improve (NASDAQ:CLPT) - Seeking Alpha
(CLPT) Proactive Strategies - Stock Traders Daily
(CLPT) Technical Pivots with Risk Controls - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Trading 3.92% Higher on Oct 9 - GuruFocus.com
Pekin Hardy Strauss Inc. Invests $541,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Oppenheimer & Co. Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
West Pharmaceutical Services (NYSE:WST) & ClearPoint Neuro (NASDAQ:CLPT) Critical Comparison - Defense World
Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI - GlobeNewswire Inc.
(CLPT) Investment Analysis - Stock Traders Daily
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - AccessWire
ClearPoint Neuro Inc (CLPT) Trading 6.12% Higher on Nov 14 - GuruFocus.com
ClearPoint (CLPT) Gains An FDA Approval, Driving Market Interest - Stocks Telegraph
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Deliv - PharmiWeb.com
ClearPoint Neuro Makes History with First FDA-Approved Brain Gene Therapy Device | CLPT Stock News - StockTitan
ClearPoint Neuro fully repays $10M converted note - MSN
Q1 Earnings Estimate for CLPT Issued By B. Riley - MarketBeat
ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ClearPoint Neuro reports robust Q3 growth, eyes FDA approvals - Investing.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro Achieves Record Q3 Revenue Growth - TipRanks
Clearpoint Neuro earnings missed, revenue topped estimates By Investing.com - Investing.com UK
ClearPoint Neuro Reports Third Quarter 2024 Results - AccessWire
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: Wha - GuruFocus.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213% - Yahoo Finance
(CLPT) Trading Report - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in ClearPoint Neuro I - GuruFocus.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - AccessWire
ClearPoint Neuro: Investors Enamored With Its Growth Prospects (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Set to Announce Quarterly Earnings on Thursday - MarketBeat
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Significant Increase in Short Interest - MarketBeat
Taylor Frigon Capital Management LLC Has $4.20 Million Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
CLPTClearPoint Neuro, Inc. Latest Stock News & Market Updates - StockTitan
ClearPoint Neuro (CLPT) Soars 6.9%: Is Further Upside Left in the Stock? - MSN
Investors bid ClearPoint Neuro (NASDAQ:CLPT) up US$51m despite increasing losses YoY, taking five-year CAGR to 27% - Simply Wall St
CLPT Stock Touches 52-Week High at $13.5 Amidst Strong Yearly Growth - Investing.com
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - ForexTV.com
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory - Insider Monkey
Cubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Cubist Systematic Strategies LLC Acquires Shares of 77,750 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clearpoint Neuro Inc 주식 (CLPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| STIGALL L. JEREMY | Chief Business Officer |
Mar 06 '24 |
Option Exercise |
0.00 |
8,889 |
0 |
50,874 |
| D'Alessandro Danilo | Chief Financial Officer |
Mar 06 '24 |
Option Exercise |
0.00 |
9,383 |
0 |
58,312 |
| BURNETT JOSEPH MICHAEL | CEO and President |
Mar 06 '24 |
Option Exercise |
0.00 |
23,704 |
0 |
274,430 |
0.23%
0.08%
자본화:
|
볼륨(24시간):